Citation Impact
1 standout
Citing Papers
BRAF — a tumour-agnostic drug target with lineage-specific dependencies
2024 Standout
Works of Matt Cross being referenced
Dabrafenib Is a Safe and Effective Therapy in Relapsed/Refractory Classical Hairy Cell Leukemia
2020
Author Peers
| Author | Genetics | OSM | PFM | Immunology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Matt Cross | 37 | 17 | 21 | 19 | 14 | 88 | |
| Sara Karandish | 2 | 100 | 3 | 306 | |||
| Ryan K. Beasley | 17 | 409 | |||||
| Jin Zhou | 18 | 371 | |||||
| M. P. K. Sorrenson | 13 | 190 | |||||
| Karen D'Silva | 2 | 1 | 12 | 339 |
All Works
Login with ORCID to disown or claim papers
Loading papers...